Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th.

The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the two essential elements that should merge into an integrated workflow for modelers and chemists to allow experiments to concentrate on the most promising molecules.

SOM Biotech uses a proprietary cutting-edge in silico platform together with various other computational tools -including the Schrödinger software- to identify new treatments for orphan diseases. As Luca Signorile highlights, “sharing knowledge with the most advanced scientific teams and taking advantage of the most advanced technologies will undoubtedly contribute to boost drug discovery and its efficacy. Our efforts aim at reducing the costs and the time needed to bring medicines to patients”.



    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.